| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1528-1157.1991.TB05883.X |
| P8608 | Fatcat ID | release_uxcqxoe54ngwja4pxym4mtyh74 |
| P698 | PubMed publication ID | 1773780 |
| P2093 | author name string | A W Peck | |
| P2860 | cites work | The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome). | Q34397881 |
| Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam | Q41969456 | ||
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | S9-12 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Clinical pharmacology of lamotrigine | |
| P478 | volume | 32 Suppl 2 |
| Q46388977 | A calcium antagonistic effect of the new antiepileptic drug lamotrigine |
| Q74762026 | A rapid liquid chromatographic method for the determination of lamotrigine in plasma |
| Q91622282 | A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation |
| Q34580010 | Antiepileptic drugs in the treatment of neuropathic pain |
| Q59621087 | Between-subject variability: should high be the new normal? |
| Q35026378 | Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones |
| Q44443742 | Clinical Pharmacology of Topiramate versus Lamotrigine versus Phenobarbital: Comparison of Efficacy and Side Effects Using Odds Ratios |
| Q40918364 | Comparative pharmacokinetics of the newer antiepileptic drugs |
| Q52189715 | Discriminative stimulus effects of glutamate release inhibitors in rats trained to discriminate ethanol. |
| Q48406844 | Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats |
| Q33785399 | Epidemiology and drug treatment of epilepsy in elderly people |
| Q77776632 | Epilepsy in the elderly |
| Q82855287 | Epilepsy in the elderly |
| Q28241339 | Epilepsy: contemporary perspectives on evaluation and treatment |
| Q24514895 | Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin. |
| Q42707559 | Interstitial pneumonitis during lamotrigine therapy |
| Q48122191 | Lack of effect of the novel anticonvulsant SB-204269 on voltage-dependent currents in neurones cultured from rat hippocampus |
| Q73453217 | Lamotrigine analysis in plasma by gas chromatography-mass spectrometry after conversion to a tert.-butyldimethylsilyl derivative |
| Q36673011 | Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders |
| Q35802744 | Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service |
| Q40720372 | Lamotrigine clinical pharmacokinetics |
| Q36307850 | Lamotrigine for neuropathic pain |
| Q80967336 | Lamotrigine in multihandicapped therapy-resistant epileptic patients |
| Q42549347 | Lamotrigine pharmacokinetics in patients receiving felbamate |
| Q51536263 | Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study. |
| Q34306763 | Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy |
| Q34006439 | Lamotrigine. A review of its use in childhood epilepsy |
| Q40932340 | Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy |
| Q34228876 | Lamotrigine: a review of its use in bipolar disorder |
| Q40529594 | Lamotrigine: an antiepileptic agent for the treatment of partial seizures |
| Q33993665 | Newer anticonvulsants: comparative review of drug interactions and adverse effects. |
| Q44405609 | Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects |
| Q35173870 | Pharmacological treatment effects on eye movement control |
| Q40849421 | Pharmacotherapeutic issues for women of childbearing age with epilepsy |
| Q40387137 | Place of newer antiepileptic drugs in the treatment of epilepsy |
| Q35215650 | Seizures in elderly patients with dementia: epidemiology and management |
| Q34799823 | The new antiepileptic drugs |
| Q72113793 | The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalised dystomia |
| Q24658110 | The role of lamotrigine in the management of bipolar disorder |
| Q33668889 | Treatment of epilepsy in the elderly |
| Q44563095 | Unusual side effects of lamotrigine therapy |
| Q37203259 | Use of second-generation antiepileptic drugs in the pediatric population |
| Q36053921 | Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children |
Search more.